Literature DB >> 19046764

Bio-mimetic surface engineering of plasmid-loaded nanoparticles for active intracellular trafficking by actin comet-tail motility.

Chee Ping Ng1, Thomas T Goodman, In-Kyu Park, Suzie H Pun.   

Abstract

Intracellular transport after endosomal escape presents one of the major barriers for efficient non-viral gene delivery because plasmid DNA and synthetic nanoparticulate carriers suffer from significantly restricted diffusion in the cytoplasm. We postulate that forces generated by actin polymerization, a mechanism used by several bacterial pathogens such as Listeria monocytogenes, can be harnessed to propel nanoparticles within the cytoplasm and thereby overcome diffusional limitations associated with gene transport in the cell cytoplasm. In this work, we synthesized and characterized plasmid DNA-containing nanoparticles modified with ActA protein, the single protein in L. monocytogenes responsible for activating actin polymerization and initiating actin comet-tail propulsion. The motility of the ActA-modified nanoparticles was assessed in Xenopus laevis cytoplasmic extract supplemented with fluorescently labeled actin. Nanoparticle motility was monitored using multi-color, time-lapse fluorescence microscopy for the formation of actin comet tails attached to the fluorescently labeled vehicle. We observed particle motility with velocities approximately 0.06 microm/s with anionic-charged plasmid carriers formed from either poly(lactic-co-glycolic acid) (PLGA) or 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) liposomes, but interestingly not with cationic particles assembled by encapsulation of plasmid with either polyethylenimine (PEI) or 1,2-dioleoyl-3-trimethylammonium-propane/1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOTAP/DOPE) lipids. Control particles coated with albumin instead of ActA also showed no motility. Taken together, we have demonstrated the feasibility of translating the comet-tail propulsion mechanism to synthetic drug carriers as a potential approach to overcome intracellular transport barriers, and also have identified appropriate gene delivery systems that can be employed for this mechanism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19046764      PMCID: PMC2773560          DOI: 10.1016/j.biomaterials.2008.10.059

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  44 in total

1.  The role of substrate curvature in actin-based pushing forces.

Authors:  Ian M Schwartz; Morton Ehrenberg; Michael Bindschadler; James L McGrath
Journal:  Curr Biol       Date:  2004-06-22       Impact factor: 10.834

2.  Biophysical parameters influence actin-based movement, trajectory, and initiation in a cell-free system.

Authors:  Lisa A Cameron; Jennifer R Robbins; Matthew J Footer; Julie A Theriot
Journal:  Mol Biol Cell       Date:  2004-03-05       Impact factor: 4.138

3.  Cell cycle extracts.

Authors:  A W Murray
Journal:  Methods Cell Biol       Date:  1991       Impact factor: 1.441

4.  L. monocytogenes-induced actin assembly requires the actA gene product, a surface protein.

Authors:  C Kocks; E Gouin; M Tabouret; P Berche; H Ohayon; P Cossart
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

5.  Listeria monocytogenes moves rapidly through the host-cell cytoplasm by inducing directional actin assembly.

Authors:  G A Dabiri; J M Sanger; D A Portnoy; F S Southwick
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

6.  Force generation by cytoskeletal filament end-tracking proteins.

Authors:  Richard B Dickinson; Luzelena Caro; Daniel L Purich
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

7.  PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles.

Authors:  Swaroop Mishra; Paul Webster; Mark E Davis
Journal:  Eur J Cell Biol       Date:  2004-04       Impact factor: 4.492

8.  A novel bacterial virulence gene in Listeria monocytogenes required for host cell microfilament interaction with homology to the proline-rich region of vinculin.

Authors:  E Domann; J Wehland; M Rohde; S Pistor; M Hartl; W Goebel; M Leimeister-Wächter; M Wuenscher; T Chakraborty
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

9.  Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes.

Authors:  L G Tilney; D A Portnoy
Journal:  J Cell Biol       Date:  1989-10       Impact factor: 10.539

10.  PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium.

Authors:  Maytal Bivas-Benita; Stefan Romeijn; Hans E Junginger; Gerrit Borchard
Journal:  Eur J Pharm Biopharm       Date:  2004-07       Impact factor: 5.571

View more
  6 in total

Review 1.  The pharmacology of regenerative medicine.

Authors:  George J Christ; Justin M Saul; Mark E Furth; Karl-Erik Andersson
Journal:  Pharmacol Rev       Date:  2013-07-01       Impact factor: 25.468

2.  Poly(lactic-co-glycolic) acid microspheres encapsulated in Pluronic F-127 prolong hirudin delivery and improve functional recovery from a demyelination lesion.

Authors:  Drew L Sellers; Tae Hee Kim; Christopher W Mount; Suzie H Pun; Philip J Horner
Journal:  Biomaterials       Date:  2014-07-23       Impact factor: 12.479

3.  The effect of environmental pH on polymeric transfection efficiency.

Authors:  Han Chang Kang; Olga Samsonova; Sun-Woong Kang; You Han Bae
Journal:  Biomaterials       Date:  2011-11-29       Impact factor: 12.479

Review 4.  Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.

Authors:  Forrest M Kievit; Miqin Zhang
Journal:  Adv Mater       Date:  2011-08-15       Impact factor: 30.849

5.  Pathogen-inspired drug delivery to the central nervous system.

Authors:  Rebecca L McCall; Joseph Cacaccio; Eileen Wrabel; Mary E Schwartz; Timothy P Coleman; Rachael W Sirianni
Journal:  Tissue Barriers       Date:  2014-08-08

6.  Nanoparticles engineered to bind cellular motors for efficient delivery.

Authors:  Inmaculada Dalmau-Mena; Pablo Del Pino; Beatriz Pelaz; Miguel Ángel Cuesta-Geijo; Inmaculada Galindo; María Moros; Jesús M de la Fuente; Covadonga Alonso
Journal:  J Nanobiotechnology       Date:  2018-03-30       Impact factor: 10.435

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.